Browse the evidence

For patients on GLP-1 receptor agonists, adequate protein intake and strength training are necessary to mitigate muscle mass loss associated with rapid weight loss, while dietary adjustments (smaller, lower-fat meals, fiber) help manage gastrointestinal side effects.

If you are taking GLP-1 medication, prioritize protein and strength training to protect your muscles. Manage GI side effects by eating smaller, lower-fat meals and using fiber supplements if needed. Avoid high-intensity exercise if it exacerbates nausea or diarrhea.

Contemporary obesity management medications (OMMs) like semaglutide and tirzepatide cause significant lean mass loss (25-40% of weight lost), necessitating specific lifestyle interventions (resistance training and adequate protein) to mitigate muscle loss and maintain metabolic health.

If you are taking a GLP-1 or similar weight loss medication, expect to lose some muscle along with fat. To protect your strength and metabolism, prioritize resistance training and ensure you are eating enough protein. These lifestyle steps are critical complements to the medication.

HMB (3 g/day) and Creatine (5 g/day) supplementation, combined with resistance training, helps preserve lean body mass and strength during GLP-1RA-induced weight loss.

If you are doing resistance training, consider taking 3g of HMB and 5g of Creatine daily. These supplements help protect your muscles and strength while you lose weight on GLP-1RA medication.

Combining GLP-1 based therapies (GBTs) with individualized nutritional and physical activity interventions is necessary to preserve lean muscle mass, mitigate gastrointestinal adverse effects, and optimize long-term weight management outcomes.

When starting a GLP-1 medication like Ozempic or Wegovy, do not rely on the drug alone. You must actively manage your diet and exercise. Aim for 1.2 to 1.5 grams of protein per kilogram of your body weight every day, and engage in resistance training (weight lifting) at least twice a week alongside 150 minutes of moderate cardio. If you experience nausea, eat smaller, more frequent meals and stay hydrated. This combination prevents muscle loss and helps you stick with the treatment.

A structured, telehealth-based Individualized Virtual Integrative Medicine (IVIM) protocol combined with semaglutide (branded or compounded) significantly enhances weight loss outcomes, achieving an average 19.5% total body weight reduction at 52 weeks.

If you have obesity and are using semaglutide, sticking to a structured care plan that includes regular medical check-ins, coaching, and app-based tracking can lead to significant weight loss (approx. 20% over a year). This holds true whether you use the branded version or a compounded version, provided you maintain continuous therapy without gaps. The key is adherence and managing side effects through professional support.

Integrating GLP-1 receptor agonist therapy with intermittent fasting and protein-optimized resistance training preserves lean mass and improves metabolic outcomes more effectively than either intervention alone.

Start GLP-1 therapy as prescribed to manage appetite. Use this reduced hunger to gradually adopt time-restricted eating (e.g., 16:8). Prioritize high-protein meals during your eating window and engage in resistance training 2-3 times per week to protect muscle. This combination aims to maximize fat loss while minimizing muscle loss and long-term drug costs.

Combining GLP-1 pharmacotherapy with promyogenic agents (e.g., bimagrumab, enobosarm), structured resistance exercise, and targeted nutrition (protein/HMB) mitigates lean mass loss and improves functional outcomes compared to GLP-1 monotherapy.

Do not rely on GLP-1 medication alone. To protect your muscles and strength, you must combine your medication with resistance exercise, ensure you are eating enough protein, and ask your doctor about emerging combination therapies like promyogenic agents that specifically target muscle preservation.

Achieving a BMI <25 kg/m2 is associated with a significantly greater reduction in predicted 10-year atherosclerotic cardiovascular disease (ASCVD) risk compared to maintaining a BMI ≥25 kg/m2, regardless of whether the weight loss is achieved via tirzepatide or placebo.

If you have obesity or overweight, aiming for a BMI below 25 kg/m2 may offer greater protection against heart disease and stroke than stopping at a smaller weight loss. This target is increasingly achievable with modern medications like tirzepatide, which help achieve significant weight reduction. While current guidelines suggest 5-15% weight loss, this analysis indicates that reaching a 'normal' BMI might provide additional cardiovascular benefits, particularly for those with existing risk factors like high blood pressure or NAFLD.

Combined aerobic and resistance exercise provides additive or synergistic benefits for MASLD by simultaneously enhancing oxidative metabolism and increasing skeletal muscle mass.

For the best results, combine aerobic exercise (like brisk walking or cycling) with resistance training (like weight lifting). Aim for 150-300 minutes of moderate aerobic activity and 2-3 resistance sessions per week. This combination targets both your liver's fat processing and your muscle's ability to use energy, providing a comprehensive metabolic benefit.

Whole-food, nutrient-dense diets that reduce ultra-processed food consumption are effective for weight management and metabolic health.

Focus on eating whole, nutrient-dense foods and minimize ultra-processed foods. This approach supports weight management and metabolic health through energy balance, hormonal regulation, and gut microbiota effects.

A multimodal metabolic health intervention emphasizing therapeutic carbohydrate reduction (TCR) and intermittent fasting, supported by remote monitoring and coaching, produces robust 1-year weight loss (mean 15.5%) and significant medication deprescription in patients with obesity and type 2 diabetes.

If you have obesity or type 2 diabetes, consider a structured program that combines a low-carbohydrate diet (under 30g carbs/day) with remote health monitoring and coaching. This approach can lead to significant weight loss (around 15%) and may allow you to reduce or stop diabetes and blood pressure medications under medical supervision, potentially saving money and avoiding medication side effects.

High-Intensity Interval Training (HIIT) is more effective for fat loss and muscle retention in younger obese adults (18-30 years), whereas Moderate-Intensity Continuous Training (MICT) is preferred for middle-aged (31-40) and older (41-60) adults due to better adherence and sustainability.

If you are under 30 and obese, HIIT may offer faster fat loss and muscle retention. If you are over 30, prioritize Moderate-Intensity Continuous Training (MICT) like brisk walking or cycling, as it is equally effective for fat loss but easier to stick with and safer for joints.

A 12-month digital weight management program integrating tirzepatide with behavioral coaching achieves clinically meaningful weight loss (mean 22.7%) and significant improvements in binge eating and depressive symptoms.

If you have obesity and are considering medication, a structured program that combines tirzepatide with digital coaching and support can lead to significant weight loss (over 22% on average) and improvements in mental health and binge eating. Expect some initial side effects like nausea, but these often subside, and clinical support is available to help you manage them.

Adopting a Mediterranean diet and maintaining adequate protein intake (1.1–1.2 g/kg/day) are essential public health strategies to prevent chronic diseases, sarcopenia, and functional decline in older adults.

To age healthily, prioritize a Mediterranean-style diet rich in plants, fish, and olive oil, and ensure you are eating enough protein—specifically 1.1 to 1.2 grams per kilogram of your body weight daily. This higher protein target is crucial for preventing muscle loss (sarcopenia) and maintaining your ability to live independently. Combine this with regular physical activity, including resistance and balance exercises, to support your physical and cognitive health.

Low-carbohydrate diets (LCDs) and calorie restriction can improve cognitive function and combat age-related cognitive decline through mechanisms involving reduced oxidative stress, anti-inflammatory responses, and enhanced neurogenesis.

Limit carbohydrates to less than 20% of your calories, focusing on fats and proteins from meat, poultry, fish, eggs, cheese, nuts, and seeds. This approach may help combat age-related cognitive decline, especially if you have obesity or type 2 diabetes. Monitor your lipid profile as high fat intake can raise LDL.

Higher Dietary Inflammatory Index (DII) scores are independently associated with an increased risk of Coronary Heart Disease (CHD), with a 1-unit increase in DII corresponding to an odds ratio of 1.049 for CHD after adjusting for confounders.

Focus on reducing pro-inflammatory foods and increasing anti-inflammatory ones, specifically paying attention to carbohydrate quality, ensuring adequate Vitamin C and Iron intake. While you don't need to calculate a complex index, these specific nutrients appear to drive the inflammatory response linked to heart disease risk.

The association between Dietary Inflammatory Index (DII) and Coronary Heart Disease (CHD) is mediated by metabolic and lipid indicators, specifically Triglyceride-Glucose (TyG) index, Visceral Adiposity Index (VAI), Body Mass Index (BMI), Waist-to-Height Ratio (WHtR), High-Density Lipoprotein (HDL), and Glomerular Filtration Rate (GFR).

Managing weight, blood sugar, and cholesterol through diet can help mitigate the heart disease risk associated with inflammatory diets. Specifically, improving HDL and reducing visceral fat are key steps.

The adverse impact of Dietary Inflammatory Index (DII) on Coronary Heart Disease (CHD) is more pronounced in individuals aged <75 years, females, those with low cholesterol levels, and those with low Framingham risk scores.

If you are young, female, or have low traditional heart disease risk, your diet's inflammatory potential may have a disproportionately larger impact on your heart health compared to high-risk individuals.

Resistance training significantly improves muscle strength and physical function in older adults with sarcopenia, but the magnitude of improvement often fails to exceed the Minimal Important Difference (MID) thresholds for clinical relevance.

For older adults with sarcopenia, resistance training is beneficial for strength but may not be enough to restore full functional independence on its own. To maximize benefits, aim for a high frequency (3 times/week) and a total weekly volume around 1220 MET-min/week for grip strength, or 600 MET-min/week for walking speed. However, manage expectations: these improvements might not be large enough to drastically change daily functional status without additional interventions.

Higher training frequency (3 times/week vs. 2 times/week) and specific resistance types (Constant for knee extension, Combined for gait speed) are key effect modifiers for optimizing resistance training outcomes in sarcopenia.

To maximize strength gains from resistance training, aim for 3 sessions per week rather than 2. If your goal is knee strength, constant resistance machines may be best. If your goal is walking speed, a mix of resistance types (combined) might be superior. Individualize your program based on these specific goals.

Cluster sets (CS) elicit similar muscular hypertrophy to traditional sets (TS) when volume (sets/reps) and effort (RIR 0-1) are equated.

If you prefer cluster sets (pausing between reps/blocks), you can build muscle just as effectively as traditional sets, provided you match the total number of reps and train close to failure (0-1 reps in reserve). Don't worry about the total weight moved being lower in CS; focus on hitting your rep targets with high effort.

Nutritional supplementation can attenuate quadriceps muscle atrophy and promote hypertrophy following ACL injury and reconstruction through three primary mechanisms: direct stimulation of muscle protein synthesis, indirect enhancement of training capacity, and direct effects on satellite cell proliferation.

If you have had ACL surgery, do not rely on exercise alone to rebuild your thigh muscle. Incorporate nutritional strategies that support muscle protein synthesis (like adequate protein intake) and potentially supplements like creatine or caffeine (if appropriate for your rehab phase) to help your muscles grow and recover more effectively than exercise alone.

Creatine supplementation may enhance muscle hypertrophy following ACL injury by increasing intramuscular phosphocreatine, thereby improving high-intensity exercise capacity, and potentially stimulating mTOR and satellite cell proliferation.

Consider creatine supplementation during the later stages of your ACL rehab when you start doing more intense exercises. It can help your muscles generate energy faster and may support muscle growth.

Combining pharmacotherapy with lifestyle interventions (diet/exercise) or bariatric surgery yields superior weight loss and maintenance compared to either intervention alone.

For the best long-term results, do not rely on medication or diet/exercise alone. Use medication to help manage hunger while you establish sustainable diet and exercise habits. This combination is proven to help you keep the weight off after you stop the medication.